With recently enacted rules for edible medical cannabis in Florida, Wana Brands and AltMed Florida announce an exclusive licensing agreement to allow AltMed Florida to produce and distribute Wana Edibles at MÜV™ Medical Cannabis Dispensaries (once approved by the Florida Department of Health’s Office of Medical Marijuana Use). AltMed Florida is one of the fastest-growing companies in the state, with 25 MÜV Dispensaries open now and 15 more in development throughout Florida.
“Through our partnership with AltMed Florida, Wana Brands will now be able to offer Floridians an alternative form of cannabis consumption that can better fit their health needs,” said Nancy Whiteman, CEO, Wana Brands. “This proven partnership helped to build Wana into the No. 1 selling edible in Arizona and looks to do the same in Florida through the AltMed Florida division.”
The partnership between Wana Brands, an industry leader in cannabis-infused products and the No. 1 edibles brand in the United States, and AltMed Florida, a vertically integrated cannabis company with a state-of-the-art indoor cultivation facility in Apollo Beach, is one centered on a mutual attention to quality products and services.
Illustrating this is how Wana’s cannabis-infused products are consistently judged to be best-in-class in multiple and year-over-year evaluations by media and industry observers. AltMed Florida, which has a mission to provide the highest quality and variety of cannabis products to its patients, was recently awarded the 2019 Leafbuyer Award for Best Product Selection in a Florida Cannabis Dispensary.
“We know our Florida patients are always best served by the highest-quality products we can offer,” said John Tipton, CEO of AltMed Florida. “Through this partnership with Wana Brands, we will have another quality alternative for our cannabis patients to experience.”
This partnership will bring Wana, America’s number one edible brand, exclusively to MÜV Medical Cannabis Dispensaries making it available to the more than 409,000 active patients in Florida.
Wana Brands’ products are held to the strictest quality standards. All of Wana’s products have undergone rigorous third-party testing since the company was launched in 2010. Wana Edibles are expected to be on MÜV Medical Cannabis Dispensary shelves later this year, pending all required approvals from the Florida Department of Health’s Office of Medical Marijuana Use.
Wana Brands: Enhance your life.
Included in the 2020 Inc. 5000 list at #2,074 and boasting a three-year growth rate of 203%, Wana Brands is the No. 1 edibles brand in the United States, with more dollars sold than any other brand, according to BDS Analytics 2019 Brand Share Report. Wana leads the industry in quality, consistency and potency, providing a range of different options that enable customers to create the specific cannabis experience they want. Wana products offer diverse product forms including edibles, vapes, and extended-release capsules, four different CBD/THC ratios as well as a variety of different dosages, onset times and duration of effects. The portfolio is designed so products can be used singly or in combination to address specific health, wellness, and recreational needs. Wana products are available in Colorado, California, Illinois, Maryland, Michigan, Ohio, Arizona, Oregon and Oklahoma dispensaries, with Missouri and Florida (as regulations allow) among the states imminently coming online. Wana Brands is also available internationally in Canada. For more information or to subscribe to Wana’s e-newsletter, visit http://www.wanabrands.com.
The MÜV™ brand of medical cannabis infused products launched in Arizona in 2016 and quickly gained international attention and recognition. MÜV Dispensaries by AltMed Florida was formed a year later through the partnership of AltMed Enterprises and Plants of Ruskin, a multi-generational Florida agricultural leader. Through continual research and development, MÜV has received multiple patents for its award-winning MÜV Products line that provides quality, consistent and reliable medical cannabis products to patients at all 29 locations (one in Arizona muv-az.com, 28 in Florida muvfl.com, and more added each month). Patients are encouraged to place reservations online at muvfl.com for in-store pickup, order for delivery, or visit any one of the 27 MÜV Dispensaries for alternative medical cannabis medicine you can trust.
With a focus on quality and attention to detail, Plants of Ruskin has more than 35 years of experience in providing seedlings to farmers for vegetable and medical product production. Plants of Ruskin founders, the Dickman Family, are 4th generation farmers with a long history of working in conjunction with the University of Florida, including an endowed chair specifically dedicated to plant improvement.
Alternative Medical Enterprises, LLC, headquartered in Sarasota, FL and doing business as AltMed Enterprises, is a fully integrated medical cannabis company that brings compassion, community engagement and pharmaceutical industry precision to the development, production and dispensing of medical cannabinoids.
Forward-Looking Statements - To the extent any statements made in this press release contain information that is not historical, these statements are forward-looking in nature and merely express our beliefs, expectations or opinions. For example, words such as “may,” “should,” “estimates,” “predicts,” “continues,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “potential,” “strategy” and similar expressions are intended to identify forward-looking statements. Such statements are based on current expectations or estimates and involve a number of known and unknown risks and uncertainties that could cause our actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, the following: (i) our ability to implement our business strategy of distributing high quality cannabis products where permissible under applicable law; (ii) availability and cost of additional capital; (iii) our ability to attract, retain and motivate qualified employees and management; (iv) the impact of federal, state or local government regulations; (v) competition in the cannabis industry; (vi) our ability to generate revenues; and (vii) litigation in connection with our business. All forward-looking statements included in this press release and attributable to us or any person acting on our behalf are qualified by this cautionary statement. Forward-looking statements speak only as of the date on which they are made, and, except as required by law, we undertake no obligation to update or revise any forward-looking statement, regardless of whether new information becomes available, future developments occur or otherwise.